NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SonarMD

SonarMD

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://sonarmd.com/

Last Round

Seed Round

Mar 4, 2026

Total Funding Raised

$14.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SonarMD is a healthtech company that provides a value-based care coordination platform for managing complex chronic gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Vertical SaaS

Business Model

B2B2C

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

care coordination platformvalue-based careremote patient monitoringRPMgastroenterology softwarechronic disease managementpatient-reported outcomespredictive analyticscare managementhealth techPMPMper-member per-monthIBD caredigital healthvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SonarMD Comparables

Compare SonarMD with similar companies based on industry and business-model similarity.

SonarMD comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Salvo Health
84%
Trellus Health plc
83%
Cylinder Health
79%

SonarMD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 4, 2026
Series A ExtensionMay 1, 2023
Series ADec 17, 2018

Key People

Founding team and executive leadership

Beth Houck

Chief Executive Officer

Executive Team

Julie Schokora

Chief Operating Officer

Executive Team

SonarMD Investors

Notable investors and investment history

SonarMD investors
InvestorRounds
Arboretum VenturesSeries A
Blue Venture FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 7, 32% of headcount.

  • May 1, 2023

    $4.3M round completed.

SonarMD Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SonarMD Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SonarMD's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range22
Year Founded2015
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.